Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03618134
Title	Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner
Recruitment	Terminated
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Jonsson Comprehensive Cancer Center
Indications	oral squamous cell carcinoma pharynx squamous cell carcinoma
Therapies	Durvalumab Durvalumab + Tremelimumab
Age Groups:	senior \| adult
Covered Countries	USA